New pan-Canadian neuromuscular network unites doctors, researchers, and patients for better research and care

Network lead Dr Hanns Lochmüller

Network lead Dr Hanns Lochmüller

A new Canadian network for neuromuscular disease was launched today in Ottawa, the home of its coordination hub. NMD4C (NMD for Canada) received catalyst funding from the Canadian Institutes of Health Research and Muscular Dystrophy Canada to develop solutions that will enable healthcare professionals, researchers and patients to work together and share expertise.

The network brings together leading neuromuscular experts from across the country who will work with patient advocacy organizations including Muscular Dystrophy Canada, Jesse’s Journey and the Ottawa-Gatineau Myotonic Dystrophy Support Group on an ambitious three-year work program. The funds will help develop vital research infrastructure resources including a unique “virtual” biobank that will enable researchers to locate the precious samples they need for their research, no matter where they are in the country, and will go towards further development of the Canadian Neuromuscular Disease Registry, a resource that enables patients to be registered for research into their condition and potential clinical trial opportunities. A new generation of specialist neuromuscular disease clinicians will receive training in best-practice care and in the cutting-edge diagnostic techniques such as genome-wide sequencing that are revolutionizing diagnosis of these genetic disorders, while young scientists will be encouraged to pursue a research career in neuromuscular disease through new placement opportunities that will enable them to see the patients their research benefits. Patients living with neuromuscular diseases will have opportunities to receive training in research and ethics methodology so that they are empowered to advocate for themselves in a research context and steer research policy towards their priorities, and will participate in updates to best-practice care guidelines that will be rolled out to all participating centres across the country.

NMD4C is coordinated from Ottawa by the CHEO Research Institute’s Dr Hanns Lochmüller, a world-renowned neuromuscular clinician-scientist who has led international networking initiatives in Europe and has a career-long commitment to collaborative science and data sharing.

Dr Lochmüller said: “We’re absolutely delighted to receive this catalyst funding for our NMD4C network. Because neuromuscular diseases are individually rare, but collectively affect many children and adults across Canada, working together, pooling expertise and developing shared infrastructure on a national level is essential if we want to make rapid progress towards giving all Canadian patients world-class care and developing new treatments. This is a fantastic opportunity for doctors, researchers and the patient community to come together to do just that, and we can’t wait to get started.”

The coordinating centre and other network sites will be recruiting staff to work on the project – see this news item for details.

canada-nmd4c

Read next...

Text reading NMD4C joins bluesky - We're now active on Bluesky! We invite you to follow us at @nmd4c.ca to stay updated on news from our Canadian neuromuscular network. NMD4C and bluesky logo, with an image of the NMD4C bluesky feed.

You Can Now Find NMD4C on Bluesky

We’re moving to Bluesky! The NMD4C will now share updates on Bluesky instead of X. Please consider following us at @nmd4c.ca to stay connected! 

CIHR Funds Interdisciplinary Project to Study SBMA in Indigenous Peoples of the Prairie Provinces The NMD4C is excited to share that network investigators Drs. Gerald Pfeffer, Alexandra King, Kerri Schellenberg, Toshifumi Yokota and Malcolm King have been awarded funding from the CIHR for an Interdisciplinary Spinal-bulbar muscular atrophy study in Indigenous peoples of the prairie provinces

CIHR Funds Interdisciplinary Project to Study SBMA in Indigenous Peoples of the Prairie Provinces

The NMD4C is excited to share that network investigators have been awarded funding from the CIHR for an Interdisciplinary Spinal-bulbar muscular atrophy study in Indigenous peoples of the prairie provinces, addressing the community needs, and developing clinical knowledge and therapies.

2025 NMD4C early career award winners profile pictures, text reading Congratulations Early Career Award Winners

NMD4C Presents the 2025 Early Career Award Recipients

We are excited to announce the recipients of the 2025 NMD4C Early Career Awards! This is the third year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

LEARNMD content update - February 2025

New Content Available in LEARNMD

LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!

RQAS logo

Quebec Network Réseau Québécoise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group

We are thrilled to announce that the RQAS, a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy has officially become a sub-group Community of Practice of the NMD4C